Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
88 Cards in this Set
- Front
- Back
Reserpine
|
blocks VMAT, depletes catecholamines, prevents release of NE
|
|
Cocaine
|
NET and DAT inhibitor, prolonging of action of dopamine and NE in synapse
|
|
Imipramine
|
NET inhibitor, prolongs action of NE in synapse by blocking reuptake
|
|
Amitriptyline
|
NET inhibitor, prolongs action of NE in synapse by blocking reuptake
|
|
Phenelzine
|
Irreversible MAOI: blocks destruction of catecholamines, nonselective
|
|
Tranylcypromine
|
Irreversible, nonselective MAOI; blocks destruction of catecholamines
|
|
Isocarboxazid
|
Irreversible, nonselective MAOI; blocks destruction of catecholamines.
|
|
Selegiline
|
Selective irreversible MAO-B inhibitor MAOI
|
|
Pargyline
|
Selective MAO-B MAOI
|
|
Nialamide (Nardil)
|
MAO-I, nonselective
|
|
Entacapone
|
COMT inhibitor, increases dopamine, no peripheral action
|
|
Tolcapone
|
COMT inhibitor, increases dopamine, no peripheral action
|
|
Phenoxybenzamine
|
α-receptor antagonist, nonselective, irreversible, causes vasodilation
|
|
Propranolol
|
β-blocker, nonselective, does not block α receptors, blocks vasocontriction, reduces CO
|
|
Clonidine
|
α2 agonist, reduce sympathetic output of CNS
|
|
Phenylephrine
|
α1 agonist, vasocontrictor
|
|
Methoxamine
|
α1 agonist, vasoconstrictor, used in treatment of shock
|
|
Methyldopa
|
inhibitor of L-amino acid decarboxylase (enzyme that converts DOPA--> dopamine) = decrease dopamine
|
|
Atenolol
|
β1 blocker- blocks vasoconstriction
|
|
Metoprolol
|
β1 blocker, used in mild-moderate heart failure and after first MI, can prolong life
|
|
Botulinum toxin
|
binds presynaptic terminals, blocks ACh release
|
|
Darifenacin (Enablex)
|
M3 receptor antagonist, prevents muscle contraction
|
|
Dobutamine
|
β1 receptor agonist, increases contractility and CO
|
|
Terbutaline
|
β2 agonist, inhaled bronchodilator
|
|
Prazosin
|
α1 antagonist, blocks vasconstriction
|
|
Yohimbine
|
α2 antagonist--> more NE release that activates α1 receptors
|
|
Atropine
|
blocks ALL M-ACh receptors
|
|
Methacoline
|
Nonselective M receptor agonist
|
|
Carbachol
|
M and N type agonist
|
|
Bethanechol
|
M-ACh agonist, NO N-receptor effects
|
|
Pilocarpine
|
M receptor agonist, used for glaucoma, dry mouth
|
|
Metoclopramide
|
cholinergic agonist and dopamine antagonist
|
|
Cevimeline
|
M3 agonist, like Pilocarpine is a sialogogue (induce salivation)
|
|
Scopolamine
|
M-ACh antagonist
|
|
Belladonna alkaloids
|
M antagonist
|
|
Ipratropium
|
Nonselective M receptor blocker- inhibits bronchoconstriction and mucus secretion
|
|
Tiotroprium (Spiriva)
|
Selective M1 and M3 antagonist-bronchodilator
|
|
Tolterodine (Detrol)
|
nonselective M receptor antagonist- reduces contraction
|
|
Trospium (Sanctura)
|
nonselective muscarinic antagonist- reduces contraction
|
|
Oxybutynin
|
Nonselective M receptor antagonist- reduces contraction
|
|
Solifenacin (Vesicare)
|
Selective M3 antagonist- reduces contraction
|
|
Homatropine
|
M-receptor antagonist used in the eye
|
|
Tropicamide
|
M-antagonist
|
|
Methscopolamine
|
M-antagonist
|
|
Glycopyrrolate
|
M antagonist
|
|
Mepenzolate
|
M antagonist
|
|
Propantheline
|
Nonselective M antagonist
|
|
Physostigmine
|
AChE inhibitor: more ACh in synapse
|
|
Tacrine (Cognex)
|
AChE inhibitor
|
|
Edrophonium
|
AChE inhibitor
|
|
Donepezil (Aricept)
|
AChE inhibitor- more ACh in synapse
|
|
Neostigmine
|
AChE inhibitor
|
|
Pyridostigmine
|
AChE inhibitor
|
|
Demecarium
|
AChE inhibitor
|
|
Rivastgmine
|
AChE inhibitor
|
|
Echothiophate
|
organophophorus AChE inhibitor-irreversible
|
|
Galantamine (Razadyne)
|
AChE inhibitor
|
|
Ambenomium
|
AChE inhibitor
|
|
α-Methyltyrosine
|
Tyrosine hydroxylase inhibitor
|
|
Guanethidine
|
catecholamine storage inhibitor
|
|
Guanadrel
|
catecholamine storage inhibitor
|
|
Amphetamine
|
catecholamine storage inhibitor
|
|
Pseudoephedrine
|
Catecholamine storage inhibitor
|
|
Methylphenidate
|
Catecholamine storage inhibitor
|
|
Iproniazid
|
Nonselective MAOI
|
|
Brofaromine
|
Reversible MAO-A inhibitor
|
|
Befloxatone
|
reversible MAO-A inhibitor
|
|
Moclobemide
|
reversible MAO-A inhibitor
|
|
Oxymetazoline (Afrin)
|
α1 agonist
|
|
Tetrahydrazine (Visine)
|
α1 agonist
|
|
Guanabenz
|
α2 agonist
|
|
Guanfacine
|
α2 agonist
|
|
Isoproterenol
|
nonselective β agonist
|
|
Metaproterenol
|
β2 selective agonist
|
|
Albuterol
|
β2 selective agonist
|
|
Salmeterol (Serevent)
|
β2 selective agonist
|
|
Tamsulosin
|
α1A antagonist
|
|
Terozosin + Doxazosin
|
α1 receptor antagonist
|
|
Nadolol
|
nonselective β antagonist
|
|
Timolol
|
nonselective β antagonist
|
|
Labetolol
|
blocks α1, β1 and β2
|
|
Carvedilol
|
blocks α1, β1 and β2
|
|
Pindolol
|
β blockers
|
|
Acebutolol
|
partial β1 agonist
|
|
Esmolol
|
β1 antagonist
|
|
Celiprolol
|
β1 antagonist, β2 agonist
|
|
Hyoscyamine
|
M- recepetor inhibitor
|
|
Dicyclomine
|
M-receptor inhibitor
|